Effects of Vocal Exercises for Spasmodic Dysphonia
Effects of Vocal Exercise Following Botox Injection on Voice Handicap and Communicative Participation for Adductor Spasmodic Dysphonia
1 other identifier
interventional
15
1 country
1
Brief Summary
The purpose of this study is to assess the effect of voice exercise and voice rest on subject's perception of vocal handicap and communicative participation following Botox injections for adductor spasmodic dysphonia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 28, 2014
CompletedFirst Submitted
Initial submission to the registry
August 31, 2017
CompletedFirst Posted
Study publicly available on registry
November 21, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 25, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 25, 2018
CompletedMay 23, 2019
May 1, 2019
4 years
August 31, 2017
May 21, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
A quantifiable difference between the effects of voice exercise vs. voice rest post Adductor Spasmodic Dysphonia botox treatment through analysis of the Voice Handicap Index Questionnaire.
Pre randomized condition and post 6 week and 12 week, participants will be asked to complete the Voice Handicap Index (VHI). The VHI Questionnaire (Voice Handicap Index) is a 30-item questionnaire divided into 3 subsections (Functional, Physical, Emotional) and a Total which measures the effect of voice problems on quality of life. Individuals mark each item on this 30-item questionnaire on a scale from 0-4 (0 being never and 4 being always). Points for each subscale are tallied and a total composite score is also given. A total score of 0-11 is considered Normal, 12-28 is considered Mild Minimal handicap, 29-56 is considered Moderate Handicap, and 57-120 is considered severe handicap.
Assessing the change of the post VHI questionnaire between groups. Data will be reported at study completion, an average of 1 year.
Study Arms (2)
Voice Exercise
ACTIVE COMPARATORRandomized participants in this group will undergo 45 minutes of voice exercise, including sustained pitches and pitch glides on a variety of different vocal facilitators.
Voice Rest
NO INTERVENTIONRandomized participants in this group will undergo 45 minutes of voice rest.
Interventions
Voice exercise will consist of sustained pitches and pitch glides on a variety of different vocal facilitators.
Eligibility Criteria
You may qualify if:
- Female
- age
- Diagnosed with pure adductor spasmodic dysphonia
- Completed 2 consecutive standard of care Botox injection into the thyroarytenoid (TA) and/or thyroarytenoid/lateral cricoarytenoid (TA/LCA) junction with the same dosage
You may not qualify if:
- Receiving Botox to other laryngeal or supraglottic musculature
- Other neuro-laryngological conditions
- Those with an average of less than two injections per year
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Wisconsin - Madison
Madison, Wisconsin, 53792, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Brienne Ruel, MS
University of Wisconsin, Madison
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 31, 2017
First Posted
November 21, 2017
Study Start
July 28, 2014
Primary Completion
July 25, 2018
Study Completion
July 25, 2018
Last Updated
May 23, 2019
Record last verified: 2019-05
Data Sharing
- IPD Sharing
- Will not share